Research Article
Lipid Peroxidation and Antioxidant Status in Nonobese Type 2 Diabetes Mellitus
Table 1
Clinical characteristics of healthy controls (HC) and diabetic subjects (DM).
| | | Control
( = 95) | DM
( = 102) | value |
| | Age (in years) | 51.5 ± 7.24 | 53.1 ± 7.86 | 0.303 | | Sex (M/F) | 49/46 | 54/48 | 0.887 | | BMI (kg/m2) | 23.20 ± 1.69 | 22.75 ± 1.67 | 0.061 | | Duration of diabetes | — | 17.9 ± 5.76 | — | | BP-systolic (mm Hg) | 127.8 ± 8.4 | 128.2 ± 7.9 | 0.201 | | BP-diastolic (mm Hg) | 81.4 ± 6.95 | 82.2 ± 6.5 | 0.146 | | FPG (mg/dL) | 80.94 ± 8.5 | 167.5 ± 60.3* | <0.001 | | PPPG (mg/dL) | 114.3 ± 9.9 | 238 ± 27.2* | <0.001 | | HbA1c (%) | 4.80 ± 0.43 | 7.48 ± 1.03* | <0.001 |
|
|
FBG, fasting blood glucose; BP, blood pressure; PPPG, postprandial blood glucose. Age, BMI, HbA1c scores, and serum levels of biochemical parameters were expressed as the mean ± SD. Statistically significant, * < 0.001.
|
